Assignee
INT AIDS VACCINE INITIATIVE
US·31 granted patents·6 pending applications·64 citations·filing 2000–2023
Top patents by PatentIndex Score
37 records- 0193USRE50268EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2022·Granted Jan 14, 2025·2 cites·30 claims
- 0293US10093720B2Broadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 9, 2018·12 cites·6 claims
- 0390US6531313B1Invasive bacterial vectors for expressing alphavirus repliconsINT AIDS VACCINE INITIATIVE·Filed 2000·Granted Mar 11, 2003·27 cites·45 claims
- 0487USRE49037EBroadly neutralizing antibody and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Apr 19, 2022·3 cites·23 claims
- 0585US9347065B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2013·Granted May 24, 2016·7 cites·4 claims
- 0684US9738688B2HIV-1 envelope glycoproteinINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Aug 22, 2017·6 cites·19 claims
- 0783US11795211B2Rapid elicitation of broadly neutralizing antibodies to HIV EnvINT AIDS VACCINE INITIATIVE·Filed 2018·Granted Oct 24, 2023·3 cites·13 claims
- 0874US10844095B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Nov 24, 2020·0 cites·7 claims
- 0974US10058604B2Soluble HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2014·Granted Aug 28, 2018·3 cites·17 claims
- 1069US2024109956A1Rapid elicitation of broadly neutralizing bovine antibodies to hiv envINT AIDS VACCINE INITIATIVE·Filed 2023·Application pending·0 cites
- 1165US10792357B2Optimized HIV envelope gene and expression thereofINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Oct 6, 2020·0 cites·9 claims
- 1264US11203617B2Immunogenic trimersINT AIDS VACCINE INITIATIVE·Filed 2018·Granted Dec 21, 2021·1 cites·7 claims
- 1363US10894080B2Transgenic VERO-CD4/CCR5 cell lineINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Jan 19, 2021·0 cites·8 claims
- 1463US10544430B2Vesicular stomatitis virus and virus rescue systemINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Jan 28, 2020·0 cites·18 claims
- 1563US10202424B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Feb 12, 2019·0 cites·11 claims
- 1663US9802986B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Oct 31, 2017·0 cites·8 claims
- 1761US10279027B2Transgenic Vero-CD4/CCR5 cell lineINT AIDS VACCINE INITIATIVE·Filed 2017·Granted May 7, 2019·0 cites·11 claims
- 1860US9382311B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Jul 5, 2016·0 cites·8 claims
- 1959US9796774B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Oct 24, 2017·0 cites·5 claims
- 2058US9402894B2Viral particles derived from an enveloped virusINT AIDS VACCINE INITIATIVE·Filed 2012·Granted Aug 2, 2016·0 cites·7 claims
- 2158US2013095556A1Novel vesicular stomatitis virus and virus rescue systemINT AIDS VACCINE INITIATIVE·Filed 2012·Application pending·0 cites
- 2254US9925258B2Replication-competent VSV-HIV Env vaccinesINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Mar 27, 2018·0 cites·10 claims
- 2353US9944935B2Methods to improve vector expression and genetic stabilityINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Apr 17, 2018·0 cites·11 claims
- 2450US9610346B2Recombinant viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Apr 4, 2017·0 cites·7 claims
- 2549US2023134571A1Engineered antibodies to hiv envINT AIDS VACCINE INITIATIVE·Filed 2020·Application pending·0 cites
- 2648US11248027B2Engineered outer domain (eOD) of HIV GP120, mutants and use thereofINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Feb 15, 2022·0 cites·5 claims
- 2748US10220087B2Optimized HIV envelope gene and expression thereofINT AIDS VACCINE INITIATIVE·Filed 2017·Granted Mar 5, 2019·0 cites·10 claims
- 2847US9931394B2Soluble HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Apr 3, 2018·0 cites·18 claims
- 2947US2015065381A1Methods of identifying novel hiv-1 immunogensINT AIDS VACCINE INITIATIVE·Filed 2014·Application pending·0 cites
- 3046US12534516B2Anti-HIV antibodiesINT AIDS VACCINE INITIATIVE·Filed 2019·Granted Jan 27, 2026·0 cites·16 claims
- 3145US10870683B2N-glycan deleted HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2018·Granted Dec 22, 2020·0 cites·14 claims
- 3245US10081796B2Neutralization-resistant CDV mutants and viral vectorsINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Sep 25, 2018·0 cites·9 claims
- 3343US9562078B2Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutationsINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Feb 7, 2017·0 cites·8 claims
- 3441US2021292396A1Enginerred antibodies to hiv envINT AIDS VACCINE INITIATIVE·Filed 2019·Application pending·0 cites
- 3538US10174292B2Soluble HIV-1 envelope glycoprotein trimersINT AIDS VACCINE INITIATIVE·Filed 2016·Granted Jan 8, 2019·0 cites·15 claims
- 3631US2016033532A1Mammalian protein co-recognition by broadly neutralizing antibodies as modified immunogens for re-elicitationINT AIDS VACCINE INITIATIVE·Filed 2015·Application pending·0 cites
- 3727US9707290B2Immunogens of HIV-1 broadly neutralizing antibodies, methods of generation and uses thereofINT AIDS VACCINE INITIATIVE·Filed 2015·Granted Jul 18, 2017·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when INT AIDS VACCINE INITIATIVE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →